Cyrille Lescop

505 total citations
21 papers, 402 citations indexed

About

Cyrille Lescop is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Cyrille Lescop has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 4 papers in Cell Biology. Recurrent topics in Cyrille Lescop's work include Sphingolipid Metabolism and Signaling (8 papers), Synthetic Organic Chemistry Methods (7 papers) and Calpain Protease Function and Regulation (3 papers). Cyrille Lescop is often cited by papers focused on Sphingolipid Metabolism and Signaling (8 papers), Synthetic Organic Chemistry Methods (7 papers) and Calpain Protease Function and Regulation (3 papers). Cyrille Lescop collaborates with scholars based in Switzerland, France and United Kingdom. Cyrille Lescop's co-authors include F. Huet, Noe͏̈lle Gauvry, Martin H. Bolli, Oliver Nayler, Philip Magnus, Laurence Mévellec, Corinne Comoy, Holger Herzner, I. Courdier-Fruh and Josef P. Magyar and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Cyrille Lescop

21 papers receiving 394 citations

Peers

Countries citing papers authored by Cyrille Lescop

Since Specialization

Citations

This map shows the geographic impact of Cyrille Lescop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrille Lescop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrille Lescop more than expected).

Fields of papers citing papers by Cyrille Lescop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrille Lescop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrille Lescop. The network helps show where Cyrille Lescop may publish in the future.

Co-authorship network of co-authors of Cyrille Lescop

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrille Lescop. A scholar is included among the top collaborators of Cyrille Lescop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrille Lescop. Cyrille Lescop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a Novel Orally Active, Selective LPA Receptor Type 1 Antagonist, 4-(4-(2-Isopropylphenyl)-4-((2-methoxy-4-methylphenyl)carbamoyl)piperidin-1-yl)-4-oxobutanoic Acid, with a Distinct Molecular Scaffold 2024 ·Journal of Medicinal Chemistry ·Cyrille Lescop, Christine Brotschi, (unknown), Christoph P. Sager, Magdalena Birker, Keith Morrison, Sylvie Froidevaux, Stéphane Delahaye, Oliver Nayler, Martin H. Bolli	2
2	Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases 2024 ·Journal of Medicinal Chemistry ·Cyrille Lescop, Magdalena Birker, Christine Brotschi, (unknown), Keith Morrison, Sylvie Froidevaux, Stéphane Delahaye, Oliver Nayler, Martin H. Bolli	4
3	S1P1 Modulator-Induced Gi Signaling and β-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In Vivo 2017 ·Molecular Pharmacology ·Magdalena Birker, Martin H. Bolli, Markus Rey, Ruben de Kanter, Christopher Kohl, Cyrille Lescop, (unknown), (unknown), Beat Steiner, Oliver Nayler	4
4	Cenerimod, a novel selective S1P₁ receptor modulator with unique signaling properties 2017 ·Pharmacology Research & Perspectives ·Luca Piali, Magdalena Birker, Cyrille Lescop, Sylvie Froidevaux, Nicole Schmitz, Keith Morrison, Christopher Kohl, Markus Rey, R. O. Studer, Enrico Vezzali, Patrick Hess, Martine Clozel, Beat Steiner, Martin H. Bolli, Oliver Nayler	26
5	Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines 2016 ·European Journal of Medicinal Chemistry ·Martin H. Bolli, Cyrille Lescop, Magdalena Birker, Ruben de Kanter, Patrick Hess, Christopher Kohl, Oliver Nayler, Markus Rey, Patrick Sieber, (unknown), Thomas Weller, Beat Steiner	12
6	Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups 2016 ·European Journal of Medicinal Chemistry ·Cyrille Lescop, (unknown), (unknown), Magdalena Birker, Ruben de Kanter, Christopher Kohl, Patrick Hess, Oliver Nayler, Markus Rey, Patrick Sieber, Beat Steiner, Thomas Weller, Martin H. Bolli	11
7	Practical Synthesis of a S1P Receptor 1 Agonist via a Guareschi–Thorpe Reaction 2016 ·Organic Process Research & Development ·G. Schmidt, Martin H. Bolli, Cyrille Lescop, Stefan Abele	7
8	Novel S1P₁ Receptor Agonists − Part 3: From Thiophenes to Pyridines 2013 ·Journal of Medicinal Chemistry ·Martin H. Bolli, Stefan Abele, Magdalena Birker, Roberto Bravo, Daniel Bur, Ruben de Kanter, Christopher Kohl, (unknown), Patrick Hess, Cyrille Lescop, (unknown), (unknown), Oliver Nayler, Markus Rey, Michael W. Scherz, G. Schmidt, Jürgen Seifert, Beat Steiner, (unknown), Thomas Weller	15
9	Synthetic Sphingosine 1-Phosphate Receptor Modulators - Opportunities and Potential Pitfalls 2011 ·Current Topics in Medicinal Chemistry ·Martin H. Bolli, Cyrille Lescop, Oliver Nayler	27
10	Effect of calpain and proteasome inhibition on Ca ²⁺ ‐dependent proteolysis and muscle histopathology in the mdx mouse 2008 ·The FASEB Journal ·Alexandre Briguet, Michael A. Erb, I. Courdier-Fruh, Patrizia Barzaghi, (unknown), Holger Herzner, Cyrille Lescop, (unknown), (unknown), Philipp Weyermann, Josef P. Magyar, (unknown), Günther Metz, Thomas Meier	43
11	Substituted Cyclobutenes, Their Preparation, and Their Versatility in Synthesis 2007 ·ChemInform ·Noe͏̈lle Gauvry, Cyrille Lescop, F. Huet	40
12	Synthesis and Evaluation of Calpain Inhibitors Carrying Muscle Cell Targeting Groups 2006 ·Letters in Drug Design & Discovery ·Philipp Weyermann, Holger Herzner, Cyrille Lescop, (unknown), (unknown), (unknown), Christian Rummey, Alexandre Briguet, I. Courdier-Fruh, Michael A. Erb, Mark Foster, (unknown), (unknown), (unknown)	4
13	Substituted Cyclobutenes, Their Preparation, and Their Versatility in Synthesis 2006 ·European Journal of Organic Chemistry ·Noe͏̈lle Gauvry, Cyrille Lescop, F. Huet	47
14	Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy 2005 ·Bioorganic & Medicinal Chemistry Letters ·Cyrille Lescop, Holger Herzner, (unknown), (unknown), (unknown), Philipp Weyermann, Alexandre Briguet, I. Courdier-Fruh, Michael A. Erb, Mark Foster, Thomas Meier, Josef P. Magyar, (unknown)	26
15	A New Synthesis of 2-Azabicyclo[2.1.1]hexanes 2001 ·The Journal of Organic Chemistry ·Cyrille Lescop, Laurence Mévellec, F. Huet	31
16	Photo-Fries rearrangement for the synthesis of the diazonamide macrocycle 2001 ·Tetrahedron Letters ·Philip Magnus, Cyrille Lescop	26
17	Stereoselective synthesis of a [3.3.0]-fused γ-butyrolactone. Application in the preparation of bicyclic nucleosides 2000 ·Tetrahedron Letters ·Cyrille Lescop, (unknown), F. Huet	6
18	ChemInform Abstract: A New Synthesis of cis‐Cyclobut‐3‐ene‐1,2‐dicarboxylic Anhydride. 1999 ·ChemInform ·Noe͏̈lle Gauvry, Corinne Comoy, Cyrille Lescop, F. Huet	1
19	A New Synthesis of cis-Cyclobut-3-ene-1,2-dicarboxylic Anhydride 1999 ·Synthesis ·Noe͏̈lle Gauvry, Corinne Comoy, Cyrille Lescop, F. Huet	31
20	Digests or extracts??Some interesting but conflicting results for three widely differing polluted sediment samples 1995 ·Microchimica Acta ·Iain L. Marr, (unknown), (unknown), (unknown), Cyrille Lescop	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact